These phenomena reveal that RES has the potential to hamper EMT stimulated by LPA through suppression of YB-1/EZH2 signaling axis in breast cancer cells, preventing the invasion and metastasis, as well as sensitizing the treatment of 5-FU (31). The gene discussed is YBX1; the disease is breast carcinoma.